Submit Deal

NEOGENOMICS

Summary

NeoGenomics operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 425 M

Avg. Deal Size£ 213 M

Market Context

Senior Management

Kathryn B. McKenzie
CFO
Charlie Eidson
Investors Relations Manager
Denise E Pedulla
In-house Counsel

Sort

td cowen

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 281 M

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 281 M

Total Value

ropes & gray

HQ - Boston

legal advisors (2)

2 Shared Deals

2 For

£ 425 M

Total Value

perella weinberg partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 281 M

Total Value

k&l gates

HQ - Pittsburgh

legal advisors (1)

1 Shared Deal

1 Opposite

£ 281 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy